Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-06-18EMA Authorised: Phelinun (melphalan hydrochloride) — ADIENNE S.r.l. S.U.
The EMA authorised Phelinun (melphalan hydrochloride) for multiple cancers including multiple myeloma, Hodgkin lymphoma, non-Hodgkin lymphom…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing
An ongoing clinical trial update describes using phased variant analysis with next-generation sequencing to enable early assessment of lymph…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases [Phase 2]
A Phase 2 clinical trial is testing alpha/beta T cell and CD19+ B cell depletion in allogeneic stem cell transplantation for malignant disea…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma [Phase 2]
Phase 2 clinical trial evaluating chemoradiotherapy with targeted immunotherapy for pediatric lymphomas. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Brentuximab Vedotin With or Without Nivolumab in Treating Patients With Relapsed or Refractory CD30+ Lymphoma [Phase 2]
Clinical trial update for a Phase 2 study evaluating brentuximab vedotin with or without nivolumab in patients with relapsed or refractory C…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma [Phase 2]
A Phase 2 clinical trial is evaluating isatuximab during stem cell collection and subsequent transplant in patients with multiple myeloma an…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Palifermin (Kepivance) in patients undergoing unrelated donor allogeneic hematopoietic cell transplant…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL [Phase 1]
Phase 1 study of TAA-specific cytotoxic T lymphocytes (TACTAL) for Hodgkin lymphoma and non-Hodgkin lymphoma; the trial is currently active …
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis [Phase 2]
A Phase 2 trial (ABBA CORD) evaluating donor-derived cord blood T cells with abatacept for prophylaxis of acute graft-versus-host disease in…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation [Phase 2]
Phase 2 trial comparing three GVHD prophylaxis regimens in nonmyeloablative or reduced-intensity conditioning unrelated donor transplantatio…
-
CLINICAL_TRIALS trial_result · 2025-05-26Clinical Trial Update: Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating direct tumor microinjection and FDG-PET to test drug sensitivity in patients with relapsed or refractory n…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
An ongoing clinical trial is evaluating whether dexrazoxane hydrochloride affects biomarkers linked to cardiomyopathy and heart failure afte…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III
A prospective cohort study on lymphoma sponsored by Samsung Medical Center is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Administration of T Lymphocytes for Prevention of Relapse of Lymphomas [Phase 1]
Phase 1 clinical trial update evaluating administration of T lymphocytes to prevent relapse in Hodgkin lymphoma and other lymphomas; results…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Early Ageing During Therapy in AYA Cancer Patients
A clinical trial investigating early ageing during therapy in adolescents and young adults with cancer is currently recruiting. The study co…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab with involved-site radiation therapy for early-stage relapsed or primary refractory Hodgki…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
This completed clinical trial (NCT05053100) investigates the risk of blood clots and bleeding in patients with hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation [Phase 2]
Phase 2 trial evaluating tocilizumab to prevent graft-versus-host disease after cord blood transplantation has been completed.
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment [Phase 2]
Phase 2 trial evaluating autologous hematopoietic stem cell transplantation in children with relapsed or refractory Hodgkin lymphoma after n…
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Pediatric Hodgkin Lymphoma Treatment Trial With Low Cumulative Doses of Chemotherapy Agents and Reduced Radiation. [Phase 4]
A Phase 4 pediatric Hodgkin lymphoma trial is assessing lower cumulative doses of chemotherapy with reduced radiation and is currently recru…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Phase II Trial of BrECADD in HIV-Positive Patients With Advanced-Stage Classical Hodgkin Lymphoma [Phase 2]
Phase II trial investigating BrECADD in HIV-positive patients with advanced classical Hodgkin lymphoma; status not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation [Phase 1]
Phase 1 study evaluating itacitinib for prophylaxis of graft-versus-host disease and cytokine release syndrome after T-cell replete haploide…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors [Phase 2]
A Phase 2 trial evaluating α/β+-T lymphocyte-depleted donor grafts from HLA-mismatched donors in multiple hematologic malignancies was termi…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma [Phase 2]
An update on a Phase 2 trial of pembrolizumab as first-line treatment for advanced-stage classical Hodgkin lymphoma. The study is currently …
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL [Phase 2]
A Phase 2 trial evaluating ipilimumab with or without nivolumab in relapsed/refractory Hodgkin lymphoma has posted results.